Suppr超能文献

肺纤维化中的细胞外超氧化物歧化酶

Extracellular superoxide dismutase in pulmonary fibrosis.

作者信息

Gao Fei, Kinnula Vuokko L, Myllärniemi Marjukka, Oury Tim D

机构信息

Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, USA.

出版信息

Antioxid Redox Signal. 2008 Feb;10(2):343-54. doi: 10.1089/ars.2007.1908.

Abstract

Disruption of the oxidant/antioxidant balance in the lung is thought to be a key step in the development of many airway pathologies. Hence, antioxidant enzymes play key roles in controlling or preventing pulmonary diseases related to oxidative stress. The superoxide dismutases (SOD) are a family of enzymes that play a pivotal role protecting tissues from damage by oxidant stress by scavenging superoxide anion, which prevents the formation of other more potent oxidants such as peroxynitrite and hydroxyl radical. Extracellular SOD (EC-SOD) is found predominantly in the extracellular matrix of tissues and is ideally situated to prevent cell and tissue damage initiated by extracellularly produced ROS. EC-SOD has been shown to be protective in several models of interstitial lung disease, including pulmonary fibrosis. In addition, alterations in EC-SOD expression are also present in human idiopathic pulmonary fibrosis (IPF). This review discusses EC-SOD regulation in response to pulmonary fibrosis in animals and humans and reviews possible mechanisms by which EC-SOD may protect against fibrosis.

摘要

肺中氧化剂/抗氧化剂平衡的破坏被认为是许多气道疾病发展的关键步骤。因此,抗氧化酶在控制或预防与氧化应激相关的肺部疾病中起关键作用。超氧化物歧化酶(SOD)是一类酶,通过清除超氧阴离子在保护组织免受氧化应激损伤方面发挥关键作用,超氧阴离子的清除可防止其他更强效氧化剂如过氧亚硝酸盐和羟基自由基的形成。细胞外超氧化物歧化酶(EC-SOD)主要存在于组织的细胞外基质中,非常适合预防由细胞外产生的活性氧引发的细胞和组织损伤。EC-SOD已被证明在包括肺纤维化在内的几种间质性肺病模型中具有保护作用。此外,人类特发性肺纤维化(IPF)中也存在EC-SOD表达的改变。本文综述了动物和人类中EC-SOD对肺纤维化的调节作用,并探讨了EC-SOD可能预防纤维化的机制。

相似文献

1
Extracellular superoxide dismutase in pulmonary fibrosis.
Antioxid Redox Signal. 2008 Feb;10(2):343-54. doi: 10.1089/ars.2007.1908.
2
Altered expression of extracellular superoxide dismutase in mouse lung after bleomycin treatment.
Free Radic Biol Med. 2001 Nov 15;31(10):1198-207. doi: 10.1016/s0891-5849(01)00699-2.
3
Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan.
J Biol Chem. 2008 Mar 7;283(10):6058-66. doi: 10.1074/jbc.M709273200. Epub 2007 Dec 28.
4
Oxidative stress alters syndecan-1 distribution in lungs with pulmonary fibrosis.
J Biol Chem. 2009 Feb 6;284(6):3537-45. doi: 10.1074/jbc.M807001200. Epub 2008 Dec 9.
5
Enhanced bleomycin-induced pulmonary damage in mice lacking extracellular superoxide dismutase.
Free Radic Biol Med. 2003 Oct 1;35(7):763-71. doi: 10.1016/s0891-5849(03)00402-7.
6
Redistribution of pulmonary EC-SOD after exposure to asbestos.
J Appl Physiol (1985). 2004 Nov;97(5):2006-13. doi: 10.1152/japplphysiol.00480.2004. Epub 2004 Aug 6.
7
Leukocyte-derived extracellular superoxide dismutase does not contribute to airspace EC-SOD after interstitial pulmonary injury.
Am J Physiol Lung Cell Mol Physiol. 2012 Jan 1;302(1):L160-6. doi: 10.1152/ajplung.00360.2010. Epub 2011 Oct 14.
8
Role of extracellular superoxide dismutase in bleomycin-induced pulmonary fibrosis.
Am J Physiol Lung Cell Mol Physiol. 2002 Apr;282(4):L719-26. doi: 10.1152/ajplung.00058.2001.
10
Extracellular superoxide dismutase protects against matrix degradation of heparan sulfate in the lung.
Antioxid Redox Signal. 2008 Feb;10(2):261-8. doi: 10.1089/ars.2007.1906.

引用本文的文献

2
In silico, in vitro, and in vivo assessment of chitosan-diltiazem nanoparticles against pulmonary fibrosis.
Ther Deliv. 2025 Jun;16(6):555-568. doi: 10.1080/20415990.2025.2478803. Epub 2025 Mar 24.
4
Exploration of SOD3 from gene to therapeutic prospects: a brief review.
Mol Biol Rep. 2024 Sep 13;51(1):980. doi: 10.1007/s11033-024-09919-2.
5
Inside the genome: understanding genetic influences on oxidative stress.
Front Genet. 2024 Jun 25;15:1397352. doi: 10.3389/fgene.2024.1397352. eCollection 2024.
6
Antrodia cinnamomea extract alleviates bleomycin-induced pulmonary fibrosis in mice by inhibiting the mTOR pathway.
Biomed J. 2024 Dec;47(6):100720. doi: 10.1016/j.bj.2024.100720. Epub 2024 Apr 26.
7
An evaluation of trace elements and oxidative stress in patients with benign paroxysmal positional vertigo.
PLoS One. 2023 Feb 22;18(2):e0277960. doi: 10.1371/journal.pone.0277960. eCollection 2023.
8
Theophylline Attenuates BLM-Induced Pulmonary Fibrosis by Inhibiting Th17 Differentiation.
Int J Mol Sci. 2023 Jan 5;24(2):1019. doi: 10.3390/ijms24021019.
10
Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis.
Front Pharmacol. 2022 Jan 21;12:794997. doi: 10.3389/fphar.2021.794997. eCollection 2021.

本文引用的文献

1
Extracellular superoxide dismutase protects against matrix degradation of heparan sulfate in the lung.
Antioxid Redox Signal. 2008 Feb;10(2):261-8. doi: 10.1089/ars.2007.1906.
2
Apical oxidative hyaluronan degradation stimulates airway ciliary beating via RHAMM and RON.
Am J Respir Cell Mol Biol. 2007 Aug;37(2):160-8. doi: 10.1165/rcmb.2006-0413OC. Epub 2007 Mar 29.
4
Hyperoxia modulates TGF-beta/BMP signaling in a mouse model of bronchopulmonary dysplasia.
Am J Physiol Lung Cell Mol Physiol. 2007 Feb;292(2):L537-49. doi: 10.1152/ajplung.00050.2006. Epub 2006 Oct 27.
5
Transactivation of epidermal growth factor receptor by insulin-like growth factor 1 requires basal hydrogen peroxide.
FEBS Lett. 2006 Oct 2;580(22):5161-6. doi: 10.1016/j.febslet.2006.08.068. Epub 2006 Sep 5.
8
Matrix regulation of lung injury, inflammation, and repair: the role of innate immunity.
Proc Am Thorac Soc. 2006 Jul;3(5):401-4. doi: 10.1513/pats.200604-097AW.
9
Antioxidant therapeutic targets in COPD.
Curr Drug Targets. 2006 Jun;7(6):707-20. doi: 10.2174/138945006777435254.
10
Classification and natural history of the idiopathic interstitial pneumonias.
Proc Am Thorac Soc. 2006 Jun;3(4):285-92. doi: 10.1513/pats.200601-005TK.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验